A Study of Special Use Results Surveillance of Revlimid 5mg Capsules

Clinical trial NCT02921802 · COMPLETED

Trial details

NCT number: NCT02921802
Sponsor: Celgene
Status: COMPLETED
Study type: OBSERVATIONAL

Multiple Myeloma Myelodysplastic Syndromes

Start date: 2010-07-20
Primary completion: 2013-03-29
Enrollment: 4626

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.